Review Article
Article ID:
20070811111749
Pulmonary complications are a signifi cant cause of early mortality (up to 100 days) after hematopoietic stem cell transplantation (HSCT). While infectious complications particularly due to opportunistic pathogens are common in these patients, diffuse lung injury is a non-infectious complication occurring in 25-50% of HSCT recipients. The incidence of this complication is higher with allogeneic as apposed to autologous transplants and is largely dependant on the method of graft versus host prophylaxis.






